AMR Action Fund CEO Henry Skinner appeared on the “Vital Health” podcast and discussed a wide range of topics pertaining to antibiotic R&D. The episode highlighted the history of antibiotics and how their discovery transformed human health. It also touched on contemporary market challenges that antibiotic developers face and the need for policy reforms to support antibiotic R&D, as well as new research showing that cancer patients are highly susceptible to antibiotic-resistant infections.
Listen to the full episode here.
